Details for New Drug Application (NDA): 206679
✉ Email this page to a colleague
NDA 206679 describes FLOLIPID, which is a drug marketed by Salerno Pharms and is included in one NDA. There are two patents protecting this drug. Additional details are available on the FLOLIPID profile page.
The generic ingredient in FLOLIPID is simvastatin. There are forty drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the simvastatin profile page.
The generic ingredient in FLOLIPID is simvastatin. There are forty drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the simvastatin profile page.
Summary for 206679
| Tradename: | FLOLIPID |
| Applicant: | Salerno Pharms |
| Ingredient: | simvastatin |
| Patents: | 2 |
Medical Subject Heading (MeSH) Categories for 206679
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 20MG/5ML | ||||
| Approval Date: | Apr 21, 2016 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Apr 26, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Feb 23, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 40MG/5ML | ||||
| Approval Date: | Apr 21, 2016 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Apr 26, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
